Introduction {#Sec1}
============

Total knee arthroplasty (TKA) is an effective treatment modality for severe osteoarthritis of the knee. Though eventual mechanical failure may be anticipated with long-term activity and normal use, as many as 28% of patients who undergo an uncomplicated TKA and postoperative course may experience persistent moderate to severe knee pain \[[@CR1], [@CR2]\]. Causes of pain following TKA are poorly understood; however, patient-specific biology and various neuropathic underlying mechanisms such as neuroma formation and complex regional pain syndrome (CRPS) have been suggested \[[@CR1], [@CR3]--[@CR5]\]. Informed consent was obtained for the publication of this case. The aim of this case study is to present the use of combination spinal cord stimulator (SCS) therapy for the management of persistent pain following TKA.

Case Report {#Sec2}
===========

Our patient was a 71-year-old Caucasian non-Hispanic male who presented with chronic left knee pain after undergoing a TKA 18 months prior. He had an uncomplicated past medical history of hypertension, hyperlipidemia, and reflux, which were well controlled with medical management. He was 70 inches tall and weighed 215 lbs. He had no history of any additional surgeries. He was married and lived at home with his wife. He was now retired and prior to his surgery maintained an active lifestyle including exercise and daily life activities. His social history included social alcohol consumption and was negative for tobacco use (Fig. [1](#Fig1){ref-type="fig"}). Fig. 1Anterior--posterior radiographic film demonstrating permanently implanted leads positioned at the top of the T8 vertebral body and spanning vertebra T8--T10

Following his TKA, the patient complained of persistent and progressively worsening post-operative pain of his knee. Orthopedic evaluation determined his implant to be normally functioning without evidence of hardware loosening or infection. On presentation, he described the pain as sharp, 7/10 (VAS) in severity though poorly defined, with radiation to the left ankle, and associated paresthesias in the same distribution. On physical exam, he experienced symptoms of hyperesthesia and allodynia along the anterior aspect of his knee. His postsurgical incision was well healed, without evidence of erythema, swelling, or gross changes in color. Strength was 5/5 with flexion and extension of the lower left leg, but was limited by guarding due to pain. His right lower extremity had 5/5 strength in all myotomes, and otherwise he had 5/5 strength in the left leg with flexion and extension of the thigh, inversion, eversion, plantar flexion, and dorsiflexion of his left foot.

Given his symptomatology of hyperesthesia, allodynia, preserved strength, and absence of orthopedic aberrancy, a diagnosis of postsurgical CRPS of the left lower extremity was made. Initial management of his pain was conservative including physical therapy, non-steroidal anti-inflammatory, muscle relaxant, neuropathic, and opioid medications, which provided little or no relief of symptoms. Following a trial of lumbar sympathetic block, he reported improvement in pain, with a reduction on VAS to 3/10, lasting approximately 1 month in duration. Given a dramatic improvement in his knee symptoms, he subsequently underwent a successful SCS trial and uneventful implantation of two 16-contact Boston Scientific leads with a Boston Scientific Spectra WaveWriter™ SCS system. His generator was programmed to provide simultaneous traditional paresthesia-based therapy at a frequency of 50 Hz along with the combination of burst therapy at a frequency of 450 Hz, with six pulses per burst, as well as sub perception stimulation therapy at a frequency of 1.2 kHz. Upon first post-procedural follow-up, the patient experienced dramatic pain relief, reporting complete resolution of his symptoms. Moreover, at 6 months post SCS implantation, he continued to experience complete resolution and had successfully completed an opioid wean to discontinuation.

Discussion {#Sec3}
==========

The development of persistent pain following TKA is a significant complication that is often challenging to treat. In the absence of mechanical pathology, surgical revision for poorly defined persistent chronic pain leads to worsened outcomes \[[@CR3]\]. Instead, a conservative approach has been demonstrated to have some benefit; in a long-term study of 18 patients who had chronic unexplained pain following surgery, 55% reported improvement with reassurance and watchful waiting at 5-year follow-up \[[@CR6]\]. Still, few therapeutic options are available to provide relief in this challenging patient population. Our case suggests that combination therapy in SCS may be an effective modality to treat CRPS in the lower extremity. Combination SCS therapy includes both paresthesia and high-frequency sub-perception-based therapies, the combination of which is customizable to improve patient pain relief. North et al., in the WHISPER study, demonstrated supporting evidence for sub-perception therapies in combination with supra-perception therapies. They found an increased 62% patient responder rate when the combination therapy was implemented in patients with chronic pain \[[@CR7]\]. We anticipate more data will continue to emerge and further provide supporting evidence for the safety and efficacy of combination therapy when compared to either paresthesia or sub perception-based therapies individually.

Conclusions {#Sec4}
===========

Persistent pain following TKA is an important complication and is often difficult to treat. Combination SCS may be an effective modality for the treatment of persistent pain in the lower extremity following TKA; further studies are needed to evaluate the long-term efficacy.
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